Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
7.61
+0.02 (0.26%)
At close: Nov 11, 2026, 4:00 PM EST
7.63
+0.02 (0.26%)
After-hours: Nov 11, 2026, 7:30 PM EST
Oculis Holding AG Employees
Oculis Holding AG had 60 employees as of December 31, 2025. The number of employees increased by 11 or 22.45% compared to the previous year. That makes Oculis Holding AG the 34,186th largest employer in the world and 4,524th in the United States.
Employees
60
Change (1Y)
11
Growth (1Y)
22.45%
Revenue / Employee
$18,717
Profits / Employee
-$1,609,496
Market Cap
469.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 60 | 11 | 22.45% |
| Dec 31, 2024 | 49 | 13 | 36.11% |
| Dec 31, 2023 | 36 | 8 | 28.57% |
| Dec 31, 2022 | 28 | - | - |
| Sep 30, 2022 | 32 | - | - |
| Jun 30, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| Prothena Corporation | 67 |
| Eupraxia Pharmaceuticals | 49 |
| Shattuck Labs | 40 |
| DiaMedica Therapeutics | 35 |
| Monopar Therapeutics | 22 |
| Indaptus Therapeutics | 5 |
OCS News
- 10 hours ago - Oculis Holding AG Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 2 days ago - Oculis Holding AG Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 2 days ago - Oculis to Host In-Person and Virtual R&D Day: Advancing a Differentiated Late-Stage Development Pipeline - GlobeNewsWire
- 7 days ago - Oculis price target lowered to $40 from $45 at Guggenheim - TheFly
- 8 days ago - Oculis reports Q3 EPS (30c), consensus (39c) - TheFly
- 8 days ago - Oculis Reports Q3 2026 Financial Results and Builds Momentum Toward Multiple Upcoming Pipeline Catalysts - GlobeNewsWire
- 8 days ago - Oculis Holding AG Earnings release: Q3 2026 - Filings
- 9 days ago - Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation - GlobeNewsWire